Steven E. Voskuil net worth and biography

Steven Voskuil Biography and Net Worth

Director of Bath & Body Works

Voskuil joined The Hershey Company (“Hershey”) in 2019 and is responsible for leading Hershey’s global finance organization, including financial planning and analysis, accounting and reporting, tax, treasury, internal audit and investor relations. Prior to joining Hershey, he served as Senior Vice President and Chief Financial Officer of Avanos Medical (previously Halyard Health), a global medical device company serving healthcare needs in more than 90 countries, after he led Avanos Medical’s successful spin-off from Kimberly-Clark Corporation in 2014. Prior to Avanos, he worked for 23 years at Kimberly-Clark Corporation, including serving as Chief Financial Officer of Kimberly-Clark International and Vice President and Treasurer of Kimberly-Clark Corporation. Voskuil has a BBA in Finance from the University of Wisconsin and a Master’s Degree in Management from the Stanford Graduate School of Business.

What is Steven E. Voskuil's net worth?: The estimated net worth of Steven E. Voskuil is at least $1.16 million as of January 20th, 2026. Mr. Voskuil owns 52,319 shares of Bath & Body Works stock worth more than $1,159,651 as of January 25th. This net worth approximation does not reflect any other assets that Mr. Voskuil may own. Learn More about Steven E. Voskuil's net worth.
How do I contact Steven E. Voskuil?: The corporate mailing address for Mr. Voskuil and other Bath & Body Works executives is PO Box 16000, Columbus, Ohio 43216-6000. Bath & Body Works can also be reached via phone at (614) 415-7000 and via email at [email protected]. Learn More on Steven E. Voskuil's contact information.
Has Steven E. Voskuil been buying or selling shares of Bath & Body Works?: Steven E. Voskuil has not been actively trading shares of Bath & Body Works in the last ninety days. Most recently, on Friday, November 21st, Steven E. Voskuil bought 20,000 shares of Bath & Body Works stock. The stock was acquired at an average cost of $15.04 per share, with a total value of $300,800.00. Following the completion of the transaction, the director now directly owns 33,925 shares of the company's stock, valued at $510,232. Learn More on Steven E. Voskuil's trading history.
Who are Bath & Body Works' active insiders?: Bath & Body Works' insider roster includes Wendy Arlin (CFO), Gina Boswell (CEO & Director), Lucy Brady (Director), Francis Hondal (Director), Thomas Mazurek (Chief Supply Chain Officer), Robert Schottenstein (Director), Stephen Steinour (Director), and Steven Voskuil (Director). Learn More on Bath & Body Works' active insiders.
Are insiders buying or selling shares of Bath & Body Works?: In the last year, Bath & Body Works insiders bought shares 4 times. They purchased a total of 33,513 shares worth more than $500,441.57. The most recent insider tranaction occured on November, 21st when Director Steven E Voskuil bought 20,000 shares worth more than $300,800.00. Insiders at Bath & Body Works own 0.3% of the company. Learn More about insider trades at Bath & Body Works.
Information on this page was last updated on 11/21/2025.

Steven E. Voskuil Insider Trading History at Bath & Body Works

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/21/2025	Buy	20,000	$15.04	$300,800.00	33,925

Steven E. Voskuil Buying and Selling Activity at Bath & Body Works

Bath & Body Works Company Overview

Bath & Body Works, Inc. is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. The company was founded by Leslie Herbert Wexner in 1963 and is headquartered in Columbus, OH.

Today's Range

Now: $22.17

$22.13

$22.99

50 Day Range

MA: $20.14

$14.84

$23.41

2 Week Range

Now: $22.17

$14.27

$41.87

Volume

2,905,274 shs

Average Volume

4,745,621 shs

Market Capitalization

$4.54 billion

P/E Ratio

6.82

Dividend Yield

3.60%

Beta

1.51